Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Cranberry Supplement Industry Still Lacks Manufacturing Standardization, Driving Inconsistency in Effectiveness.


News provided by

Solv Wellness®

Jun 22, 2023, 12:03 ET

Share this article

Share toX

Share this article

Share toX

While Studies Show What Makes a Cranberry Supplement Effective, Only Solv Wellness® Uses That Guidance to Set Its Own Standard, with Ellura®.

ATLANTA, June 22, 2023 /PRNewswire/ -- Solv Wellness is seeking to raise awareness of the basic science behind the mechanism of action for cranberry proanthocyanidins (PAC), and in doing so, help answer the question posed by a Cochrane review regarding standardization of cranberry PAC.

Continue Reading
The basic science behind the mechanism of action of cranberry PAC demonstrates that only PAC from concentrated juice extract, like the PAC in Ellura, have bacteria-fighting power because they are 100% soluble. The PAC in other supplements come partially or entirely from the pomace (the skin, seeds, stems, and pulp), and PAC from pomace is not soluble. Solubility is what enables the body to absorb the PAC so it can enter the urine and block bacteria from sticking to the cellular walls.
The basic science behind the mechanism of action of cranberry PAC demonstrates that only PAC from concentrated juice extract, like the PAC in Ellura, have bacteria-fighting power because they are 100% soluble. The PAC in other supplements come partially or entirely from the pomace (the skin, seeds, stems, and pulp), and PAC from pomace is not soluble. Solubility is what enables the body to absorb the PAC so it can enter the urine and block bacteria from sticking to the cellular walls.

In a recent fifth update to their original 1998 meta-analysis, Cochrane once again supports their original conclusion that products containing cranberry PAC can help prevent recurrent urinary tract infections (UTIs). In the same report, Cochrane also notes the industry suffers from lack of standardization—but stops short of saying what the standard should be.

While Cochrane has done a thorough job of reviewing published clinical studies, it's important to note that meta-analyses do not consider the basic science that proves mechanism of action and guides standardization. Other studies conducted by Amy Howell, PhD, from the Marucci Center for Blueberry and Cranberry Research at Rutgers University, and Bilal Chughtai, MD, urologist from Weill Cornell Medical College, have shown what the standard should be: 100% soluble PAC extracted from pure concentrated cranberry juice extract.

What is soluble PAC? Simply stated, soluble means the PAC is bioavailable. Solubility, or bioavailability, is key, because only soluble PAC exhibits strong bacterial anti-adhesion activity (AAA). This is the ability to inhibit uropathogenic (infectious) bacteria by binding to the parts of the bacteria that would otherwise adhere to the cellular walls of the urinary tract—type 1 pili and P fimbriae—interfering with the initial step of a urinary tract infection. When pathogenic bacteria can't stick to the urinary tract wall, they are flushed away with the urine stream in a normal and healthy manner.

Researchers from Weill Cornell Medical College and the Marucci Center for Blueberry and Cranberry Research at Rutgers University conducted two studies published in 2016 and 2021 that demonstrated soluble PAC is necessary for bacterial AAA.

In 2016, practicing urologist Bilal Chughtai, MD, and Dominique Thomas, BS, of the Weill Cornell Medical College, and research scientist Amy B. Howell, PhD, of the Marucci Center, studied 9 commercially available cranberry supplements containing PAC from different parts of the cranberry. All parts of the berry contain PAC, but only the PAC extracted from the concentrated juice of the cranberry are soluble. The PAC that come from the balance of the cranberry—the pulp, seeds, skin, and stems, also known as pomace—are not readily soluble, as noted in the American Herbal Pharmacopoeia.1

In the study, published in the American Journal of Obstetrics and Gynecology2, Chughtai, Thomas & Howell noted that the difference in PAC molecules across the supplements yielded a wide variability in bacterial AAA. While the researchers suspected solubility was the key factor, it wasn't until 2021, when they conducted a head-to-head comparison3 between Gikacran®, a compound consisting entirely of soluble PAC extracted from only concentrated cranberry juice extract, and Pacran®, a compound comprised entirely of cranberry pomace, that they had conclusive evidence to settle the verdict that PAC solubility is what drives AAA. With this study, healthcare providers now have guidance on how to advise their patients on cranberry PAC supplements for non-antibiotic UTI management.

So why hasn't 100% soluble PAC become the standard for cranberry supplement manufacturing? Because it's difficult and expensive to manufacture a supplement using PAC extracted from only the concentrated juice of cranberries, and in the United States, there isn't a governing body to mandate the standardization of food supplements.

Both studies by Howell et al. demonstrated a clear winner with respect to bacterial AAA: Ellura® by Solv Wellness. Ellura exerts 16 to 20 times more AAA than the average cranberry supplement, and as much as 4 to 5 times more AAA than the most potent insoluble whole-berry product. "There is a large variability in the amount and anti-adhesion activity of PACs in commercially available cranberry products claiming to contain 36 mg PAC," said Howell. "AAA is not detectable in some cranberry supplements."

Ellura is the only commercially available product in the US that contains Gikacran, or 100% soluble PAC from concentrated cranberry juice extract, while others contain a blend of pomace and juice (e.g., whole-berry blends) or just pomace (e.g., cranberry powder).

"We tested placebo against 18 mg, 36 mg, and 72 mg to understand what the minimum efficacious dose is for Ellura. It turns out to be 36 mg of 100% soluble PAC," said Kevin Wade, co-founder and EVP of Clinical Development at Solv Wellness, LLC. "Standardization simply means we've defined what is effective, and we replicate that every single time. Ellura is standardized to contain 36 mg of Gikacran: 100% soluble PAC extracted from only concentrated cranberry juice extract."

Ellura is backed by 20+ clinical studies, 19 traditional medicine approvals worldwide, and a Drug Master File in Europe that was built based on U.S. Food and Drug Administration standards.

About Solv Wellness, LLC

Solv Wellness, LLC, formerly known as Trophikos, LLC, delivers products backed by science for often stigmatized female pelvic health conditions. For too long, women's needs at midlife and beyond have been underserved by the scientific and healthcare communities, and as a result, many women often dread much of what aging brings. Solv Wellness is committed to helping women stay optimistic about the future by providing meaningful solutions, backed by science, to the issues women experience at midlife and beyond. Solv Wellness is the company behind Ellura®, Via™, and Māge™. Ellura is a clinically proven daily supplement for non-antibiotic management of recurrent urinary tract infections. Via is a vaginal moisturizer made with the highest-quality ingredients that help replenish moisture where women need it most. Māge is a state-of-the-art pre- and probiotic supplement that helps support the entire female pelvic triangle: the gut, vagina, and urinary tract.

For more information about Solv Wellness and its product offerings, visit solvwellness.com.
For scientific data, dosing information, and more, please visit hcp.solvwellness.com.

Contact Info:
Tamara Brown
SVP, Marketing
[email protected]
+1 (404) 618-4990

References:

1Upton R., & Brendler T., (Eds.) (2016). American Herbal Pharmacopoeia: cranberry fruit (17, 20, 22, 39, 31).

2Chughtai B., Thomas D., & Howell A. (2016). Variability of commercial cranberry dietary supplements for the prevention of uropathogenic bacterial adhesion. American Journal of Obstetrics & Gynecology. 215(1), 122-123. doi: 10.1016/j.ajog.2016.03.046.

3Howell, A., Dreyfus, J.F., & Chughtai B. (2022). Differences in urinary bacterial anti-adhesion activity after intake of cranberry dietary supplements with soluble versus insoluble proanthocyanidins. Journal of Dietary Supplements, 19:5, 621-639. doi: 10.1080/19390211.2021.1908480.

Pacran® is a registered trademark of Naturex®. Solv Wellness is not connected to or endorsed by Naturex or Pacran in any way.
Ellura® and Gikacran® are registered trademarks of Pharmatoka®.

Statements in this release have not been evaluated by the FDA.
These products are not intended to diagnose, treat, cure, or prevent any disease.

SOURCE Solv Wellness®

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Solv Wellness® Launches Menopause Made Clear™ to Tackle Critical Gaps in Menopause

Solv Wellness® Launches Menopause Made Clear™ to Tackle Critical Gaps in Menopause

While every woman who lives long enough will experience menopause, it is one of the most misunderstood and underserved areas of healthcare. Less than ...

Solv Wellness®, the Pioneers of Clinically Proven UTI Prevention, Introduces GennaMD™: The Next Generation of UTI Defense™

Solv Wellness®, the Pioneers of Clinically Proven UTI Prevention, Introduces GennaMD™: The Next Generation of UTI Defense™

Solv Wellness, a leader in women's menopause and pelvic health, is proud to announce the launch of GennaMD, its latest innovation in urinary tract...

More Releases From This Source

Explore

Household, Consumer & Cosmetics

Household, Consumer & Cosmetics

Fitness/Wellness

Fitness/Wellness

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.